2 April 2026

FDA Pharmaceuticals

FDA liver alert for avacopan

2 April 2026

Clinical research Pharmaceuticals Polymyalgia Rheumatica

Secukinumab boosts remission in PMR

2 April 2026

Axial spondyloarthritis Biologics Clinical research

Bimekizumab safety holds up with longer-term data

2 April 2026

Clinical research Dermatomyositis

Brepocitinib shows promise in phase 3 dermatomyositis trial

19 March 2026

Lupus Pharmaceuticals

More evidence for obinutuzumab in lupus patients

19 March 2026

Pharmaceuticals TGA

More treatment flexibility for myasthenia gravis patients

19 March 2026

Biologics Psoriatic Athritis

Bimekizumab and risankizumab go head-to-head

19 March 2026

FDA Psoriatic Athritis

New oral option for psoriatic arthritis wins FDA nod

5 March 2026

Pharmaceuticals TGA

TGA’s February safety updates

5 March 2026

PBS Pharmaceuticals

Myasthenia gravis medication added to PBS

5 March 2026

Pharmaceuticals Plaque psoriasis

Bimekizumab still superior at three years

5 March 2026

Biologics Lupus

Real-world lupus study shows rapid response to anifrolumab

5 March 2026

Pharmaceuticals TGA

More fake GLP-1 weight loss drugs trigger TGA alert

19 February 2026

Gastroenterology Pharmaceuticals

PPI use not linked to stomach cancer, new study finds

5 February 2026

PBAC Pharmaceuticals Rheumatology

More repeats on the way for hydroxychloroquine on PBS

11 December 2025

Osteoarthritis Pharmaceuticals Rheumatology

Experts call time on discredited arthritis injection